Skip to the page

Data / Form D filings / St. James Therapeutics Inc.

St. James Therapeutics Inc.: Form D filing

St. James Therapeutics Inc., a health care company in Akron, OH, filed a Form D with the SEC in 2023. The latest, on November 14, 2023, reports $350,000 sold of a $850,000 offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2046 AKRON PENINSULA ROAD, Akron, OH, 44313
Phone
(330) 208-6388
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Ohio
Year incorporated
2018
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2000945

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 14, 2023New notice$850,000$350,000$500,0007Aug 9, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Mark AllioExecutive Officer, Director
Michael AllioExecutive Officer, Director
Michele AllioDirector

Other health care companies in Ohio that filed recently

Every Form D from the week of Nov 13, 2023 · All recent filings in Ohio · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what St. James Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.